Skip to content

Wechelpharma

Active Risk: not assessed Private limited companyfounded 2006active for 19 yearsGebroeders De Winterstraat 32, 2275 LilleKBO/BCE: BE 0885.230.908 #6 company by equity in Lille, Finance and insurance sector

Timeline

28 events since 2006

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed PDFabbreviated format · 130 days before the deadline
2025
Highest result from 2007 to 2025 net €653,281 ▲319% The net result of €653,281 is the highest of those years.
Annual accounts 2024 filed PDFabbreviated format · 155 days before the deadline
2024
Annual accounts 2023 filed PDFabbreviated format · 149 days before the deadline
2023
Registered in the Peppol Directory Reachable for e-invoices through 0208:0885230908
Annual accounts 2022 filed PDFabbreviated format · 39 days before the deadline
Changes of role: PEETERS Jeroen Cordula Willy (director) and DEKEYSER Brigitte Evelyne (director)Director discharge: PEETERS Jeroen Cordula Willy · Director discharge: DEKEYSER Brigitte Evelyne · General meeting of 27-02-20237 points ▸

Open the deed in the Belgian Official Gazette

2022
Annual accounts 2021 filed PDFabbreviated format · 6 days before the deadline
2021
Annual accounts 2020 filed PDFabbreviated format · 32 days before the deadline
2020
Annual accounts 2019 filed PDFabbreviated format · 9 days before the deadline
2019
Annual accounts 2018 filed PDFabbreviated format · 37 days before the deadline
2018
Annual accounts 2017 filed PDFabbreviated format · 12 days before the deadline
Capital decrease of €615,974 to €18,550Capital from €634,524 to €18,550 · General meeting of 08-12-20173 points ▸
  • General meeting, 08-12-2017
  • Capital decrease, €615,974
  • Amendment of the articles, article 5
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

2017
Annual accounts 2016 filed PDFabbreviated format · 29 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 27 days late
2015
Equity above €1m equity €1.1m ▲13.1% With a profit in every financial year since 2007, equity grows to €1.1m.
Annual accounts 2014 filed PDFabbreviated format · 27 days late
2014
Annual accounts 2013 filed PDFabbreviated format · 17 days late
2013
Annual accounts 2012 filed PDFabbreviated format · on the deadline day
2012
Annual accounts 2011 filed PDFabbreviated format · 24 days late
2011
Annual accounts 2010 filed PDFabbreviated format · 2 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 2 days before the deadline
2009
Equity above €500,000 equity €517,874 ▲23.9% With a profit in every financial year since 2007, equity grows to €517,874.
Annual accounts 2008 filed PDFabbreviated format · 17 days late
2008
Equity above €200,000 equity €417,858 ▲250% With a profit in every financial year since 2007, equity grows to €417,858.
Annual accounts 2007 filed PDFabbreviated format · 6 days before the deadline
2006
First establishment Gebroeders De Winterstraat 32, Lille
Incorporation PDFpublished on 04-12-2006

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

Wechelpharma was incorporated on 24 November 2006.1 Total assets went from €2.3m in 2018 to €2.5m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Next steps